Ranadev Mukherjee, MD
Gastroenterology · N Las Vegas, NVNPI 1861593790
Payments from drug & device makers
Across 38 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$208
- Johnson & Johnson$115
- Lilly USA, LLC$106
- Boehringer Ingelheim$74
- Ferring Pharmaceuticals Inc.$57
- Novartis$55
- plus $230 from 8 others
What the payments were for
- Food & beverage$74087%
- Education$10613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $208 |
| Johnson & Johnson | 6 | $115 |
| Lilly USA, LLC | 1 | $106 |
| Boehringer Ingelheim | 3 | $74 |
| Ferring Pharmaceuticals Inc. | 3 | $57 |
| Novartis | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| GSK | 2 | $42 |
| Tersera Therapeutics LLC | 1 | $36 |
| Pharmacosmos Therapeutics Inc. | 1 | $32 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| QOL Medical, LLC | 2 | $18 |
| Accord Healthcare, Inc. | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $17 |
How this compares
$846 in reported general payments places this provider in the 25th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $75,515 |
| Mesalamine ErMesalamine | 12 | $6,145 |
| Omeprazole | 55 | $346 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $322 |
| Pantoprazole Sodium | 41 | $261 |
| Famotidine | 57 | $248 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in N Las Vegas
- George TanN Las Vegas$5K
- Jawad JilaniN Las Vegas$3K
- Shahid WahidN Las Vegas$3K
- Christian StoneLas Vegas$3.7M
- George VagujhelyiReno$825K
- Michael ZimmermanLas Vegas$717K
- Rajat SoodHenderson$258K
- Yasser SaloumNorth Las Vegas$194K
- Vishvinder SharmaNorth Las Vegas$111K
- Ting-Hui HsiehReno$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.